Banco Bilbao Vizcaya Argentaria S.A. raised its holdings in The Allstate Corporation (NYSE:ALL – Free Report) by 72.8% in the third quarter, HoldingsChannel.com reports. The firm owned 75,113 shares of the insurance provider’s stock after purchasing an additional 31,636 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Allstate were worth $16,123,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Allstate by 1.3% in the second quarter. Vanguard Group Inc. now owns 33,235,231 shares of the insurance provider’s stock valued at $6,690,584,000 after buying an additional 435,145 shares in the last quarter. Franklin Resources Inc. grew its position in Allstate by 2.5% during the second quarter. Franklin Resources Inc. now owns 4,670,113 shares of the insurance provider’s stock worth $940,140,000 after buying an additional 112,858 shares in the last quarter. Boston Partners increased its stake in Allstate by 14.9% during the 3rd quarter. Boston Partners now owns 3,050,780 shares of the insurance provider’s stock worth $654,652,000 after acquiring an additional 395,195 shares during the period. Raymond James Financial Inc. increased its stake in Allstate by 3.3% during the 2nd quarter. Raymond James Financial Inc. now owns 2,793,645 shares of the insurance provider’s stock worth $562,388,000 after acquiring an additional 88,620 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in Allstate by 18.2% in the 3rd quarter. Dimensional Fund Advisors LP now owns 2,606,451 shares of the insurance provider’s stock valued at $559,435,000 after acquiring an additional 401,700 shares in the last quarter. 76.47% of the stock is owned by institutional investors.
Insider Buying and Selling at Allstate
In related news, insider Suren Gupta sold 19,593 shares of Allstate stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average price of $210.00, for a total transaction of $4,114,530.00. Following the sale, the insider directly owned 100,646 shares of the company’s stock, valued at approximately $21,135,660. The trade was a 16.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.70% of the company’s stock.
Allstate Price Performance
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The insurance provider reported $14.31 earnings per share for the quarter, beating the consensus estimate of $8.72 by $5.59. Allstate had a return on equity of 39.20% and a net margin of 15.19%.The business had revenue of $17.35 billion for the quarter, compared to analyst estimates of $17.23 billion. During the same period last year, the firm posted $7.67 earnings per share. Allstate’s revenue was up 5.1% compared to the same quarter last year. On average, sell-side analysts expect that The Allstate Corporation will post 18.74 earnings per share for the current fiscal year.
Allstate Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Monday, March 2nd. This is an increase from Allstate’s previous quarterly dividend of $1.00. Allstate’s dividend payout ratio is 11.31%.
Analyst Ratings Changes
ALL has been the topic of several analyst reports. Zacks Research raised Allstate from a “hold” rating to a “strong-buy” rating in a report on Friday, February 20th. Raymond James Financial reaffirmed a “strong-buy” rating and issued a $260.00 price target on shares of Allstate in a research note on Tuesday, March 3rd. Wells Fargo & Company reduced their price objective on shares of Allstate from $228.00 to $227.00 and set an “equal weight” rating on the stock in a research note on Friday, February 20th. Morgan Stanley reissued an “equal weight” rating and issued a $215.00 target price (down from $245.00) on shares of Allstate in a report on Tuesday, December 16th. Finally, Evercore set a $225.00 target price on shares of Allstate in a research report on Wednesday, January 7th. Three analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $238.88.
Check Out Our Latest Research Report on ALL
Allstate Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Recommended Stories
- Five stocks we like better than Allstate
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
